New Breakthrough Cancer Medication Available in Central Oregon

Daraxonrasib has been approved by the Food and Drug Administration to treat stage 4 metastatic pancreatic cancer, according to federal records. Initial studies indicate the drug stretches typical survival times for individuals with advanced forms of the illness from six up to 13 months, introducing an alternative where medical choices were previously scarce. Early Access ... Read more